| Value | ₹200.0 Cr |
|---|
BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.
Kabra Drugs Ltd: key numbers
- Share price
- ₹16.26
- Market cap
- ₹38.55 Cr
- Revenue (annual)
- ₹92.74 Cr
- Net profit (annual)
- ₹4.96 Cr
- P/E (TTM)
- 5.1×Sector 46.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kabra Drugs Ltd
All →Kabra Drugs Other Announcement
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026. The document discloses the distribution of shareholding among various categories of investors.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited conducted its 37th Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and director appointments.
Kabra Drugs Annual Report
Aanjaay Industries Ltd has submitted its Annual Report for FY 2025-2026 and issued notice for its 37th AGM scheduled for 30th September 2026.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited announced book closure dates from September 24th to September 30th, 2026, for its Annual General Meeting scheduled for September 30th, 2026.
Kabra Drugs Board Meeting Outcome
Aanjaay Industries Limited announced the notice for its 37th Annual General Meeting and approved board agenda items, including the appointment of directors and auditors.
Kabra Drugs Other Announcement
Aanjaay Industries Limited has shifted its registered office from Indore, Madhya Pradesh, to Chennai, Tamil Nadu, effective August 28, 2026.
Other capacity expansion announcements
All →Speciality Restaurants Capacity Expansion
Speciality Restaurants launched a new restaurant named WALTERS in Malad West, Mumbai, on October 28, 2026. The filing is a Reg 30 disclosure of a domestic restaurant launch with no monetary value stated.
- new restaurant outlets
- outlets
Goodluck India Capacity Expansion: ₹80 Cr Investment
Goodluck India's subsidiary Goodluck Defence and Aerospace approved adding Aerospace Components as a new line of business. The estimated investment is Rs 80 Crore, within a previously approved capital outlay.
- Value
- ₹80.00 Cr
Borosil Scientific Capacity Expansion: ₹70 Cr Investment
Borosil Scientific approved a Rs.70 Crore, 20 MT per day glass tubing furnace. Commercial production is expected by March 2028.
- Value
- ₹70.00 Cr
- Execution
- Commercial production expected by March 31, 2028
- borosilicate glass tubing production capacity
- 20.0 MT per day
Forbes Precision Tools and Machine Parts Capacity Expansion: ₹60 Cr Investment
Forbes Precision approved a Rs.60 Crore investment to add 10 lakh units annually within 1 to 1.5 years. Funding will combine internal accruals and debt.
- Value
- ₹60.00 Cr
- Execution
- 1 to 1.5 year
- production capacity
- 10.0 lakh units per annum
Diensten Tech Capacity Expansion
Diensten Tech's board approved incorporating a UAE subsidiary in IT consultancy, with the investment amount not yet fixed. Name, capital and incorporation date will be disclosed on completion.
- Execution
- Approximately 3 months from board approval, subject to regulatory approvals
Supreme Holdings & Hospitality (India) Capacity Expansion
Supreme Holdings approved a related-party joint development deal for a Panvel plot, pending shareholder approval. The project targets about 1 lakh sq ft saleable area.
- saleable area
- 100000.0 sq ft